MEDNATION AG (EIF.DE) Fundamental Analysis & Valuation

FRA:EIF • DE0005653604

Current stock price

3.5 EUR
0 (0%)
Last:

This EIF.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. EIF.DE Profitability Analysis

1.1 Basic Checks

  • EIF had positive earnings in the past year.
  • In the past year EIF had a positive cash flow from operations.
  • In multiple years EIF reported negative net income over the last 5 years.
  • EIF had a positive operating cash flow in each of the past 5 years.
EIF.DE Yearly Net Income VS EBIT VS OCF VS FCFEIF.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

  • EIF has a Return On Assets (1.58%) which is comparable to the rest of the industry.
  • EIF has a Return On Equity (4.66%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.64%, EIF is doing worse than 77.78% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for EIF is below the industry average of 5.73%.
Industry RankSector Rank
ROA 1.58%
ROE 4.66%
ROIC 1.64%
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
EIF.DE Yearly ROA, ROE, ROICEIF.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • The Profit Margin of EIF (1.13%) is comparable to the rest of the industry.
  • The Operating Margin of EIF (2.34%) is worse than 77.78% of its industry peers.
  • In the last couple of years the Operating Margin of EIF has declined.
  • EIF has a better Gross Margin (91.35%) than 88.89% of its industry peers.
  • In the last couple of years the Gross Margin of EIF has remained more or less at the same level.
Industry RankSector Rank
OM 2.34%
PM (TTM) 1.13%
GM 91.35%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
EIF.DE Yearly Profit, Operating, Gross MarginsEIF.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EIF.DE Health Analysis

2.1 Basic Checks

  • EIF has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, EIF has less shares outstanding
  • The number of shares outstanding for EIF has been reduced compared to 5 years ago.
  • The debt/assets ratio for EIF has been reduced compared to a year ago.
EIF.DE Yearly Shares OutstandingEIF.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
EIF.DE Yearly Total Debt VS Total AssetsEIF.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 1.98 indicates that EIF is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 1.98, EIF is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • EIF has a Debt/Equity ratio of 0.98. This is a neutral value indicating EIF is somewhat dependend on debt financing.
  • EIF has a Debt to Equity ratio (0.98) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.98
ROIC/WACC0.36
WACC4.55%
EIF.DE Yearly LT Debt VS Equity VS FCFEIF.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • EIF has a Current Ratio of 1.73. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.73, EIF is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • A Quick Ratio of 1.50 indicates that EIF should not have too much problems paying its short term obligations.
  • The Quick ratio of EIF (1.50) is better than 81.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.5
EIF.DE Yearly Current Assets VS Current LiabilitesEIF.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. EIF.DE Growth Analysis

3.1 Past

  • The earnings per share for EIF have decreased strongly by -56.51% in the last year.
  • The Revenue has been growing slightly by 4.11% in the past year.
  • Measured over the past years, EIF shows a small growth in Revenue. The Revenue has been growing by 0.13% on average per year.
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EIF.DE Yearly Revenue VS EstimatesEIF.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

1

4. EIF.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • EIF is valuated rather expensively with a Price/Earnings ratio of 18.42.
  • EIF's Price/Earnings ratio is a bit cheaper when compared to the industry. EIF is cheaper than 66.67% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of EIF to the average of the S&P500 Index (26.64), we can say EIF is valued slightly cheaper.
Industry RankSector Rank
PE 18.42
Fwd PE N/A
EIF.DE Price Earnings VS Forward Price EarningsEIF.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as EIF.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.82
EIF.DE Per share dataEIF.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EIF.DE Dividend Analysis

5.1 Amount

  • No dividends for EIF!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EIF.DE Fundamentals: All Metrics, Ratios and Statistics

MEDNATION AG

FRA:EIF (4/30/2026, 7:00:00 PM)

3.5

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength65.54
Industry Growth44.67
Earnings (Last)09-30
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.13%
Ins Owner ChangeN/A
Market Cap10.92M
Revenue(TTM)50.89M
Net Income(TTM)575.90K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.42
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF 28.51
P/B 0.88
P/tB 0.89
EV/EBITDA 10.82
EPS(TTM)0.19
EY5.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.12
OCFY3.51%
SpS16.31
BVpS3.96
TBVpS3.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.11515 (17.58%)
Profitability
Industry RankSector Rank
ROA 1.58%
ROE 4.66%
ROCE 3.86%
ROIC 1.64%
ROICexc 1.8%
ROICexgc 1.8%
OM 2.34%
PM (TTM) 1.13%
GM 91.35%
FCFM N/A
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)1.97%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.43%
ROICexc growth 3YN/A
ROICexc growth 5Y6.41%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
F-Score5
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 6.43
Cap/Depr 60.09%
Cap/Sales 0.81%
Interest Coverage 3.91
Cash Conversion 20.4%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.5
Altman-Z 1.98
F-Score5
WACC4.55%
ROIC/WACC0.36
Cap/Depr(3y)35.94%
Cap/Depr(5y)25.78%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.69%
EBIT growth 3YN/A
EBIT growth 5Y-8.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-112.02%
FCF growth 3Y-18.54%
FCF growth 5Y-3.22%
OCF growth 1Y-40.8%
OCF growth 3Y-13.99%
OCF growth 5Y-5.06%

MEDNATION AG / EIF.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MEDNATION AG?

ChartMill assigns a fundamental rating of 3 / 10 to EIF.DE.


What is the valuation status for EIF stock?

ChartMill assigns a valuation rating of 1 / 10 to MEDNATION AG (EIF.DE). This can be considered as Overvalued.


What is the profitability of EIF stock?

MEDNATION AG (EIF.DE) has a profitability rating of 3 / 10.


What is the financial health of MEDNATION AG (EIF.DE) stock?

The financial health rating of MEDNATION AG (EIF.DE) is 5 / 10.


How sustainable is the dividend of MEDNATION AG (EIF.DE) stock?

The dividend rating of MEDNATION AG (EIF.DE) is 0 / 10 and the dividend payout ratio is 0%.